<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00603564</url>
  </required_header>
  <id_info>
    <org_study_id>CAPOVeRSO 01</org_study_id>
    <nct_id>NCT00603564</nct_id>
  </id_info>
  <brief_title>Helmet Continuous Positive Airway Pressure Versus Oxygen Venturi in Acute Respiratory Failure in CAP: CAPOVeRSO</brief_title>
  <acronym>CAPOVeRSO</acronym>
  <official_title>A Comparison of CPAP Delivered by Helmet and O2 Therapy With Venturi Mask for the Treatment of Acute Respiratory Failure in Community-acquired Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy of CPAP application by a helmet and O2
      administration by a Venturi mask in terms of gas exchanges improvement in patients with acute
      respiratory failure due to community-acquired pneumonia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Community-acquired pneumonia (CAP) is one of the commonest causes of hospitalised acute
      respiratory failure with a mortality rate up t 30%.

      Continuous Positive Airway Pressure (CPAP) has ben recently proved to be effective. To date,
      however, no prospective randomised study has been published on the comparison between CPAP
      and O2 administration via a Venturi mask for the treatment of acute respiratory failure in
      immunocompetent patients with community-acquired pneumonia.

      Therefore, the aim of this study is to compare the efficacy of CPAP delivered by a helmet and
      O2 administration via a Venturi mask in terms of gas exchanges improvement in early acute
      respiratory failure (PaO2/FiO2 between 210 and 285)due to community-acquired pneumonia.

      A Steering Committee composed by the principal investigators will request an interim analysis
      at 20% enrolment in order to monitor the criteria for equipoise of the two treatments.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study was prematurely interrupted because patients randomized to CPAP reached the endpoint
    quicker than anticipated in the protocol
  </why_stopped>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Reach an Improvement in Terms of Gas Exchange, Defined as a PaO2/FiO2 Ratio ≥315</measure>
    <time_frame>on admission and at 1, 6, 12, 24 and 48 hours until PaO2/FiO2 ratio ≥315</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PaO2/FiO2 Ratio Mantainance</measure>
    <time_frame>1, 6, 12, 24 and 48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Pneumonia</condition>
  <condition>Community-Acquired Infections</condition>
  <condition>Respiratory Insufficiency</condition>
  <condition>Acute Lung Injury</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPAP delivered by a helmet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>O2 administration via a conventional Venturi mask</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Castar Starmed (CPAP) delivered by a helmet</intervention_name>
    <description>Continuous Positive Airway Pressure delivered by a helmet with PEEP valve of 10 cmH2O and FiO2 0.5</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Castar Starmed CP209/2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Community-acquired pneumonia (CAP) defined as: new chest x-ray pulmonary infiltrate,
             fever, and respiratory symptoms

          -  Acute Hypoxemic Respiratory failure

          -  Respiratory Rate &lt; 35 breaths/min

          -  PaO2/FiO2 &gt; 200 and &lt; 300 while breathing oxygen for at least 15 minutes via a Venturi
             mask with FiO2 0.5

        Exclusion criteria

          -  Immunosuppression

          -  acute cardiogenic pulmonary edema

          -  Patients belonging to Class II-III-IV of the NYHA

          -  Acute coronary syndrome

          -  Acute Respiratory Acidosis pH &lt; 7.35 and PaCO2 &gt; 45 mmHg

          -  More than 3 acute organ failures

          -  Systolic Pressure &lt; 90 mmHg under fluid resuscitation or vasopressor drug use

          -  Seizures

          -  Decreased level of consciousness (GCS &lt;12)

          -  Inability to clear secretions

          -  Pre-defined intubation criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>roberto cosentini, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ospedale Maggiore Policlinico Mangiagalli e Regina Elena</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Gregg RW, Friedman BC, Williams JF, McGrath BJ, Zimmerman JE. Continuous positive airway pressure by face mask in Pneumocystis carinii pneumonia. Crit Care Med. 1990 Jan;18(1):21-4.</citation>
    <PMID>2403506</PMID>
  </reference>
  <reference>
    <citation>Hilbert G, Gruson D, Vargas F, Valentino R, Chene G, Boiron JM, Pigneux A, Reiffers J, Gbikpi-Benissan G, Cardinaud JP. Noninvasive continuous positive airway pressure in neutropenic patients with acute respiratory failure requiring intensive care unit admission. Crit Care Med. 2000 Sep;28(9):3185-90.</citation>
    <PMID>11008980</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2008</study_first_submitted>
  <study_first_submitted_qc>January 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2008</study_first_posted>
  <results_first_submitted>September 11, 2009</results_first_submitted>
  <results_first_submitted_qc>October 26, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 2, 2009</results_first_posted>
  <last_update_submitted>October 26, 2009</last_update_submitted>
  <last_update_submitted_qc>October 26, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Roberto Cosentini, MD</name_title>
    <organization>Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena</organization>
  </responsible_party>
  <keyword>CPAP</keyword>
  <keyword>community-acquired pneumonia</keyword>
  <keyword>acute respiratory failure</keyword>
  <keyword>hypoxemia</keyword>
  <keyword>Continuous Positive Airway Pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Community-Acquired Infections</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The Steering Committee requested an interim analysis at 20% enrollment in order to monitor the criteria for actual equipoise of the two treatments. Being this unplanned, the Lan-DeMets approach was followed and a manifest superiority of the CPAP treatment was identified, with a nominal alpha exceeding the criterion for interruption set at 0.00008.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>CPAP (Continuous Positive Airway Pressure)</title>
          <description>CPAP delivered by a helmet</description>
        </group>
        <group group_id="P2">
          <title>Venturi</title>
          <description>O2 administration via a conventional Venturi mask</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20">January 2006</participants>
                <participants group_id="P2" count="27">January 2006</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20">February 2008</participants>
                <participants group_id="P2" count="27">February 2008</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CPAP (Continuous Positive Airway Pressure)</title>
          <description>CPAP delivered by a helmet</description>
        </group>
        <group group_id="B2">
          <title>Venturi</title>
          <description>O2 administration via a conventional Venturi mask</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="47"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65" spread="17"/>
                    <measurement group_id="B2" value="72" spread="13"/>
                    <measurement group_id="B3" value="69" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to Reach an Improvement in Terms of Gas Exchange, Defined as a PaO2/FiO2 Ratio ≥315</title>
        <time_frame>on admission and at 1, 6, 12, 24 and 48 hours until PaO2/FiO2 ratio ≥315</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CPAP (Continuous Positive Airway Pressure)</title>
            <description>CPAP delivered by a helmet</description>
          </group>
          <group group_id="O2">
            <title>Venturi</title>
            <description>O2 administration via a conventional Venturi mask</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Reach an Improvement in Terms of Gas Exchange, Defined as a PaO2/FiO2 Ratio ≥315</title>
          <units>minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="405" spread="855"/>
                    <measurement group_id="O2" value="2437" spread="1170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>endpoint was analyzed in terms of time by comparison of mean +- SD</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PaO2/FiO2 Ratio Mantainance</title>
        <description>the number of subjects who could maintain, once reached, a PaO2/FiO2 ratio ≥315 at 1 and 24 hours after the qualifying measurement</description>
        <time_frame>1, 6, 12, 24 and 48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CPAP (Continuous Positive Airway Pressure)</title>
            <description>CPAP delivered by a helmet</description>
          </group>
          <group group_id="O2">
            <title>Venturi</title>
            <description>O2 administration via a conventional Venturi mask</description>
          </group>
        </group_list>
        <measure>
          <title>PaO2/FiO2 Ratio Mantainance</title>
          <description>the number of subjects who could maintain, once reached, a PaO2/FiO2 ratio ≥315 at 1 and 24 hours after the qualifying measurement</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.000007</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>CPAP (Continuous Positive Airway Pressure)</title>
          <description>CPAP delivered by a helmet</description>
        </group>
        <group group_id="E2">
          <title>Venturi</title>
          <description>O2 administration via a conventional Venturi mask</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limitations of our study are mainly related to the early reaching of the end-point of the CPAP group. We were not able to evaluate the safety of the CPAP application and to address conclusions on its efficacy on outcomes.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Roberto Cosentini, MD</name_or_title>
      <organization>IRCCS Fondazione Po.Ma.Re, Milan, Italy</organization>
      <phone>00390255033602</phone>
      <email>roberto.cosentini@policlinico.mi.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

